Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, 6207, Switzerland
NCT Number: NCT05777941
The new training device, the eccentric arm-crank, will be examined for its training effects in athletes with a spinal cord injury (SCI) by this project. That the training device can be used in patients with paraplegia in the future, the so-called "testing of the applicability of this concept" will be carried out during this study. Fourteen volunteer, healthy athletes with SCI are first tested for their upper body performance, followed by a training phase over 20 trainings and at the end the performance data is collected again. The training intensity and duration is continuously increased during the training phase.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Nottwil, Canton of Lucerne, 6207, Switzerland
At the beginning, the study design includes a familiarisation appointment with performance tests and training on the eccentric arm-crank device (KREHA). At least one week later, the first test sequence including a maximum strength test (bench press) and a test to determine the anaerobic performance (Wingate test) is conducted. The second test sequence takes place one to three days later. This includes a handgrip strength test, an aerobic endurance test (ramp test on the arm crank ergometer with ergospirometry) and a further familiarisation training on the KREHA. The training phase starts within two weeks after the pre-tests have been completed. There are two to a maximum of three trainings per week. These take 30 to 45 minutes and take place on the KREHA device under the supervision of the study staff. The training phase lasts a maximum of twelve weeks (20 training sessions). The first test sequence is repeated five to eight days after the last workout. The second test sequence takes place at the same time interval as in the pre-tests.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Over the twenty training sessions, able-bodied participants will exercise on the KREHA device. An arm-crank has to be decelerated, which will be rotated by a prematurely defined revolution rate and training duration. During this intervention a certain power has to be applied. During the whole time of training a continous progression in power and training duration is applied.
Time frame: through study completion, an average of 20 weeks
Peak Power - maximal reached power, generated during the 30sec Wingate arm-crank test
Time frame: through study completion, an average of 20 weeks
VO2peak [ml/min/kg] - Basic Endurance test (Ergospirometry, arm-crank)
Time frame: through study completion, an average of 20 weeks
Wmax [W] - Basic Endurance test (Ergospirometry, arm-crank)
Time frame: through study completion, an average of 20 weeks
Mean Power [W] - Wingate Test (arm-crank)
Time frame: through study completion, an average of 20 weeks
Time to Peak [s] - Wingate Test (arm-crank)
Time frame: through study completion, an average of 20 weeks
Fatigue Index [%]- Wingate Test (arm-crank)
Time frame: through study completion, an average of 20 weeks
Fatigue Slope [W/s] - Wingate Test (arm-crank)
Time frame: through study completion, an average of 20 weeks
One Repetition Maximum (1RM) [kg]- bench press
Time frame: through study completion, an average of 20 weeks
Maximal Force that can be generated by pressing hand towards a fist [N]
Time frame: through study completion, an average of 20 weeks
Circumference of the upper arm is measured with measuring tape
Time frame: through study completion, an average of 20 weeks
Circumference of the lower arm is measured with measuring tape
Swiss Paraplegic Research, Nottwil
Network
Acronym: KREHA-ParAth
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT04350359
Central Nervous System Diseases, Female Urogenital Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05822297
Central Nervous System Diseases, Cognition Disorders
Maastricht, Limburg, Netherlands
View Trial DetailsNCT04736849
Central Nervous System Diseases, Nervous System Diseases
Rochester, Minnesota, United States
View Trial Details